COVID

Updated ET, Sat ,

Novavax announced on Monday that its coronavirus vaccine was found to have an overall efficacy of 90.4% in a Phase 3 trial conducted across the United States and Mexico. ...
The former head of the FDA said that while the Delta variant currently accounts for about 10% of coronavirus infections in the U.S., it’s doubling at a rate of every two weeks meaning "it’s probably going to become the dominant strain." ...
Novavax says its shot is safe, 90 percent effective, and will be put up for emergency-use authorization in the U.S. ...
President Joe Biden mistakenly referred to COVAX, the global vaccine program, as COVID three different times during a press conference. ...

( )